Swing-Mesh™ Study (SMS).
NCT: NCT06915155 · COMPLETED
Brief Summary
This multicenter, prospective observational study aims to assess the safety and efficacy of the Swing-Mesh™ implant (THT BioScience™, distributed by B. Braun™, France) for laparoscopic-endoscopic inguinal hernia repair using TAPP or TEP techniques. Swing-Mesh™ is a lightweight, macroporous, three-dimensional mesh designed to conform anatomically to the myopectineal orifice without requiring fixation. Eligible adult patients undergoing elective repair will receive the implant. The primary endpoint is hernia recurrence within 6 months. Secondary endpoints include postoperative pain, groin discomfort, and early and late complications. The study will provide clinical evidence regarding the non-inferiority of this spatial, fixation-free mesh compared to standard devices in minimally invasive hernia surgery.
Frequently Asked Questions
What is Swing-Mesh™ Study (SMS).?
Swing-Mesh™ Study (SMS). is a clinical trial registered under NCT06915155. Current status: COMPLETED.
What is the status of NCT06915155?
The current status of NCT06915155 (Swing-Mesh™ Study (SMS).) is: COMPLETED.
When did Swing-Mesh™ Study (SMS). start?
Swing-Mesh™ Study (SMS). started on 2025-04-07.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.